UK Rare Disease Drug Review Reform Urged As Spinraza Finally Gets NICE OK

 
• By Kevin Grogan
  
Stethoscope_Coins
NICE has now recommended funding for Biogen's Spinraza • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Health Technology Assessment

More from Market Access